{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T11:25:58Z","timestamp":1791458758984,"version":"4.3.4"},"reference-count":79,"publisher":"Hindawi Limited","issue":"5","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":3794,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"DOI":"10.1111\/j.1368-5031.2005.00520.x","type":"journal-article","created":{"date-parts":[[2005,4,12]],"date-time":"2005-04-12T12:54:02Z","timestamp":1113310442000},"page":"562-570","source":"Crossref","is-referenced-by-count":57,"title":["Withdrawal syndrome following cessation of antihypertensive drug therapy"],"prefix":"10.1155","volume":"59","author":[{"given":"G. N.","family":"Karachalios","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Charalabopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Papalimneou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Kiortsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Dimicco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O. K.","family":"Kostoula","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Charalabopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"98","published-online":{"date-parts":[[2005,4,12]]},"reference":[{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB1|cit1","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1016\/0002-8703(92)90075-7","article-title":"Comparison of withdrawing antihypertensive therapy between diuretics and angiotensin converting inhibitors in essential hypertensives","volume":"124","author":"Takata","year":"1992","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB2|cit2","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1093\/ajh\/7.8.679","article-title":"Plasma renin predicts success of antihypertensive drug withdrawal","volume":"7","author":"Hog","year":"1994","journal-title":"Am J Hypertens"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB3|cit3","doi-asserted-by":"crossref","first-page":"371","DOI":"10.2165\/00003495-198428050-00001","article-title":"Cardiovascular drug withdrawal syndromes: a potential problem with calcium antagonists ?","volume":"28","author":"Raftery","year":"1984","journal-title":"Drugs"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB4|cit4","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/0002-8703(81)90317-3","article-title":"Abrupt cessation of treatment in hypertension; considerations of clinical features, mechanisms, prevention and management of the discontinuation syndrome","volume":"102","author":"Houston","year":"1981","journal-title":"Am Heart J"},{"issue":"Suppl.","key":"10.1111\/j.1368-5031.2005.00520.x-BIB5|cit5","first-page":"99","article-title":"Factors influencing the success of withdrawal of antihypertensive drug therapy","volume":"2","author":"Jennings","year":"1995;","journal-title":"Blood Press"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB6|cit6","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/0002-8703(88)90627-8","article-title":"Beta-adrenergic blocker withdrawal syndromes in hypertension and cardiovascular diseases","volume":"116","author":"Houston","year":"1988","journal-title":"Am Heart J"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2005.00520.x-BIB7|cit7","first-page":"S181","article-title":"Blood pressure overshoot due to acute clonidine (catapres) withdrawal: studies on arterial and urinary catecholamines and suggestions for management of the crisis","volume":"45","author":"Hanson","year":"1973","journal-title":"Clin Sci Mol Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB8|cit8","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/0014-2999(70)90212-8","article-title":"Studies on catecholamines, rennin and aldosterone following catapresan (2-(2,6 dichlorphenylamine)-2-imidazoline hydrochloride) in hypertensive patients","volume":"10","author":"Hokfelt","year":"1970","journal-title":"Eur J Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB9|cit9","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bmj.2.5860.209","article-title":"Effects of clonidine withdrawal: possible mechanisms and suggestions for management","volume":"2","author":"Huyor","year":"1973","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB10|cit10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00508642","article-title":"Discontinuation of chronic clonidine treatment: evidence for facilitated brain noradrenergic neurotransmission","volume":"299","author":"Svensson","year":"1977","journal-title":"Naunyn Schmiedebergs Arch Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB11|cit11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2125.1979.tb00897.x","article-title":"Clonidine withdrawal: mechanism and frequency of rebound hypertension","volume":"7","author":"Geykess","year":"1979","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB12|cit12","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/j.0954-6820.1982.tb01965.x","article-title":"Abrupt and gradual change from clonidine to \u03b2-blockers in hypertension","volume":"211","author":"Liljia","year":"1982","journal-title":"Acta Med Scand"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB13|cit13","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1136\/bmj.1.6015.942-a","article-title":"Rapid clonidine withdrawal with blood pressure overshoot exaggerated by \u03b2-blockade","volume":"1","author":"Bailey","year":"1976","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB14|cit14","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/00000542-197606000-00009","article-title":"Acute postoperative clonidine withdrawal syndrome","volume":"44","author":"Brodsky","year":"1976","journal-title":"Anesthesiology"},{"issue":"Suppl. 7","key":"10.1111\/j.1368-5031.2005.00520.x-BIB15|cit15","first-page":"128","article-title":"The overshoot phenomenon on withdrawal of clonidine therapy","volume":"52","author":"Goldberg","year":"1976","journal-title":"Postgrad Med J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB16|cit16","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/bmj.1.6071.1243","article-title":"Blood pressure and heart rate and withdrawal of antihypertensive drugs","volume":"1","author":"Goldberg","year":"1977","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB17|cit17","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/01.CIR.84.1.75","article-title":"Hemodynamic and neurohormonal effects of clonidine in patients with preganglionic and postganglionic sympathetic lesions. Evidence for a central sympatholytic action","volume":"84","author":"Konner","year":"1991","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB18|cit18","first-page":"268","article-title":"Withdrawal clonidine. Effects of varying dosage or duration of treatment on subsequent blood pressure and heart responses","volume":"206","author":"Oates","year":"1978","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB19|cit19","first-page":"395","article-title":"Central nervous system action of clonidine in hypertension","volume":"52","author":"Hoobler","year":"1977","journal-title":"Mayo Clin Proc"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB20|cit20","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/S0140-6736(77)92715-5","article-title":"Clonidine withdrawal in hypertension. Changes in blood pressure and plasma and urinary noradrenaline","volume":"1","author":"Reid","year":"1977","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB21|cit21","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1378\/chest.83.2.400","article-title":"Abrupt cessation of treatment of centrally acting antihypertensive agents. A review","volume":"83","author":"Whitsett","year":"1983","journal-title":"Chest"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB22|cit22","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1001\/jama.1979.03300190044026","article-title":"Abrupt discontinuation of clonidine therapy","volume":"242","author":"Ram","year":"1979","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB23|cit23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/clpt.1984.232","article-title":"Withdrawal phenomena are subjects with essential hypertension on clonidine or tiamenidine","volume":"36","author":"Hamilton","year":"1984","journal-title":"Clin Pharmacol Ther"},{"issue":"Suppl. 1","key":"10.1111\/j.1368-5031.2005.00520.x-BIB24|cit24","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/00005344-198000021-00008","article-title":"Discontinuation syndrome following cessation of treatment with clonidine and other antihypertensive agents","volume":"2","author":"Weber","year":"1980","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB25|cit25","first-page":"474","article-title":"Response of plasma catecholamines and blood pressure to clonidine and to sudden withdrawal of the drug in subjects with essential hypertension","volume":"20","author":"Planz","year":"1982","journal-title":"Int J Clin Pharmacol Ther Toxicol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB26|cit26","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/BF00432025","article-title":"Catecholamine metabolism during clonidine withdrawal","volume":"84","author":"Martin","year":"1984","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB27|cit27","first-page":"313","article-title":"Pheochromocytoma-like catecholamine levels induced by clonidine cessation","volume":"2","author":"Vincent","year":"1993","journal-title":"Eur J Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB28|cit28","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/0002-8703(73)90165-8","article-title":"Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management","volume":"85","author":"Hansson","year":"1973","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB29|cit29","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1001\/jama.1977.03280170028020","article-title":"Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension","volume":"238","author":"Strauss","year":"1977","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB30|cit30","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1136\/bmj.1.6017.1056","article-title":"Rebound hypertension after acute methyldopa withdrawal","volume":"1","author":"Burden","year":"1976","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB31|cit31","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1136\/bmj.2.6031.367-b","article-title":"Rebound hypertension after acute methyldopa withdrawal","volume":"2","author":"Scott","year":"1976","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB32|cit32","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1001\/jama.1962.03050090001001","article-title":"Effects of alpha-methyldopa in severe and malignant hypertension","volume":"179","author":"Cannon","year":"1962","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB33|cit33","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/cpt196782224","article-title":"Effects of methyldopa in fifty hypertensive patients","volume":"8","author":"Horwitz","year":"1967","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB34|cit34","doi-asserted-by":"crossref","first-page":"659","DOI":"10.5694\/j.1326-5377.1977.tb130994.x","article-title":"Rebound hypertension after sudden discontinuation of methyldopa therapy","volume":"1","author":"Frewin","year":"1977","journal-title":"Med J Aust"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB35|cit35","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1136\/bmj.1.6071.1243","article-title":"Blood pressure and heart rate withdrawal of antihypertensive drugs","volume":"1","author":"Collberg","year":"1977","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB36|cit36","first-page":"223","article-title":"A cross one comparison of clonidine and methyldopa in hypertension","volume":"1","author":"Conolly","year":"1972","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB37|cit37","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/j.1552-4604.1979.tb02472.x","article-title":"Withdrawal syndrome following cessation of guanabenz therapy","volume":"19","author":"Ram","year":"1979","journal-title":"J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB38|cit38","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.CIR.37.3.370","article-title":"Arterial pressure responses to discontinuing antihypertensive drugs","volume":"37","author":"Dustan","year":"1968","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB39|cit39","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0002-8703(69)90199-9","article-title":"Guanethidine and bethanidine in the management of hypertension","volume":"77","author":"Moser","year":"1969","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB40|cit40","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/0002-8703(67)90216-5","article-title":"The long-term therapy of severe hypertension with guanethidine","volume":"73","author":"Stocks","year":"1967","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB41|cit41","first-page":"57","article-title":"The use of bethanidine sulfate (Esbatal) in hypertension","volume":"6","author":"Britov","year":"1966","journal-title":"Kardiologiia"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB42|cit42","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1136\/bmj.1.5584.120-c","article-title":"Bethanidine in hypertension","volume":"1","author":"Leishman","year":"1968","journal-title":"BMJ"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB43|cit43","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0002-8703(99)70134-1","article-title":"Beta-blocker withdrawal: the song of Orfeus","volume":"138","author":"Eichorn","year":"1999","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB44|cit44","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/0002-9149(66)90052-X","article-title":"Propanolol and angina pectoris","volume":"18","author":"Wolfson","year":"1966","journal-title":"Am J Cardiol"},{"issue":"Suppl. 2","key":"10.1111\/j.1368-5031.2005.00520.x-BIB45|cit45","doi-asserted-by":"crossref","first-page":"S337","DOI":"10.1111\/j.1365-2125.1982.tb01938.x","article-title":"The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs","volume":"13","author":"Prichard","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB46|cit46","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11886-999-0042-8","article-title":"Current issues regarding beta-adrenergic blockade in patients with congestive heart failure: patient selection nonselective versus selective blockade, management of adverse effects and indications for withdrawal of therapy","volume":"1","author":"Moskowitz","year":"1999","journal-title":"Curr Cardiol Rep"},{"issue":"Suppl. 2","key":"10.1111\/j.1368-5031.2005.00520.x-BIB47|cit47","doi-asserted-by":"crossref","first-page":"S345","DOI":"10.1111\/j.1365-2125.1982.tb01939.x","article-title":"Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol","volume":"13","author":"Rangho","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB48|cit48","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1161\/01.CIR.59.6.1158","article-title":"Mechanism of propanolol withdrawal phenomena","volume":"59","author":"Nattel","year":"1979","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB49|cit49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.CIR.49.5.881","article-title":"Effect of propanolol on oxygen binding to hemoglobin in vitro and in vivo","volume":"49","author":"Lichtman","year":"1974","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB50|cit50","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1001\/archinte.1981.00340020023008","article-title":"Propanolol withdrawal. Practical considerations","volume":"141","author":"Rango","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB51|cit51","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/S0002-8703(99)70147-X","article-title":"Can beta-blocker therapy be withdrawn from patients with dilated cardiomyopathy","volume":"138","author":"Morimoto","year":"1999","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB52|cit52","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(73)90235-3","article-title":"Withdrawal of propanolol and myocardial infraction","volume":"1","author":"Slome","year":"1973","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB53|cit53","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1001\/jama.1977.03280030045021","article-title":"Hyperthyroidism after propanolol withdrawal","volume":"238","author":"Shenkman","year":"1977","journal-title":"JAMA"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB54|cit54","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1002\/cpt1978236624","article-title":"Propanolol withdrawal and thyroid hormones in patients with essential hypertension","volume":"23","author":"Kristensen","year":"1978","journal-title":"Clin Pharmacol Ther"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB55|cit55","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1136\/hrt.45.6.637","article-title":"Adrenergic hypertensitivity after beta-blocker withdrawal","volume":"45","author":"Ross","year":"1981","journal-title":"Br Heart J"},{"issue":"Suppl. 2","key":"10.1111\/j.1368-5031.2005.00520.x-BIB56|cit56","doi-asserted-by":"crossref","first-page":"S359","DOI":"10.1111\/j.1365-2125.1982.tb01941.x","article-title":"The effects of intrinsic sympathomimetic activity on b-receptor responsiveness after b-adrenoceptor blockage withdrawal","volume":"13","author":"Walden","year":"1982","journal-title":"Br J Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB57|cit57","first-page":"554","article-title":"Beta-blocker withdrawal syndrome","volume":"1","author":"Lederballe","year":"1979","journal-title":"Lancet"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB58|cit58","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/0002-8703(78)90460-X","article-title":"Abrupt propanolol withdrawal in angina pectoris. Effects on platelet aggregation and exercise tolerance","volume":"95","author":"Frishman","year":"1978","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB59|cit59","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/0002-8703(79)90428-9","article-title":"Propanolol withdrawal in angina pectoris. A prospective study","volume":"97","author":"Myers","year":"1979","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB60|cit60","first-page":"1","article-title":"Stopping \u03b2-blockers in patients with angina","volume":"15","author":"Rangno","year":"1981","journal-title":"Ration Drug Ther"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB61|cit61","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/archinte.1981.00340020055017","article-title":"Non-cardiac surgery in patients receiving propanolol. Case reports and recommended approach","volume":"141","author":"Goldman","year":"1981","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB62|cit62","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1253\/jcj.64.777","article-title":"Comparison of the electropharmacological effects of verapamil and propranolol in the halothane-anesthetized in vivo canine model under monophasic action potential monitoring","volume":"64","author":"Shiina","year":"2000","journal-title":"Jpn Circ J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB63|cit63","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1161\/01.CIR.102.7.742","article-title":"Treating electrical storm: sympathetic blockade versus advanced cardiac life support-guided therapy","volume":"102","author":"Nademanee","year":"2000","journal-title":"Circulation"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB64|cit64","first-page":"33","article-title":"National databases and clinical practice specialist: decreasing postoperative atrial fibrillation following cardiac surgery","volume":"8","author":"Halpin","year":"2004","journal-title":"Outcomes Manag"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB65|cit65","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1056\/NEJM197506052922304","article-title":"Renin release, saralasin and the vasodilator-beta-blocker drug interaction in man","volume":"292","author":"Pettinger","year":"1975","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB66|cit66","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1056\/NEJM197611182952106","article-title":"A role for rennin in rebound hypertension and encephalopathy after infusion of saralasin acetate (Sar-Ala8-angiotensin II)","volume":"295","author":"Keim","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJM197911293012201","article-title":"Rebound hemodynamic events after the abrupt withdrawal of nitroprusside in patients with severe chronic heart failure","volume":"301","author":"Packer","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB68|cit68","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/0002-8703(83)90039-X","article-title":"The acute response of plasma norepinephrine, renin activity, and arginine vasopressin to short-term nitroprusside and nitroprusside withdrawal in patients with congestive heart failure","volume":"106","author":"Francis","year":"1983","journal-title":"Am Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB69|cit69","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1016\/S0022-3476(80)80763-3","article-title":"Rebound hypertension following minoxidil withdrawal","volume":"96","author":"Makker","year":"1980","journal-title":"J Pediatr"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB70|cit70","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1476-5381.1979.tb07876.x","article-title":"Effects of verapamil, dantrolene and lanthanum on catecholamine release from the rat adrenal medulla","volume":"65","author":"Cohen","year":"1979","journal-title":"Br J Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB71|cit71","doi-asserted-by":"crossref","first-page":"22D","DOI":"10.1016\/0002-9149(86)90801-5","article-title":"Calcium-channel blockers for combined angina pectoris and systemic hypertension","volume":"57","author":"Frishman","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB72|cit72","doi-asserted-by":"crossref","first-page":"11B","DOI":"10.1016\/0002-9149(86)90404-2","article-title":"Clinical and research applications of ambulatory Holter ST-segment and heart rate monitoring","volume":"58","author":"Bala Subramanian","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB73|cit73","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/S0002-9149(84)80200-3","article-title":"Long-term efficacy of diltiazem assessed with multistage graded exercise tests in patients with chronic stable angina pectoris","volume":"54","author":"Khurmi","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB74|cit74","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/S0735-1097(83)80118-1","article-title":"Objective evaluation of three dose levels of diltiazem in patients with chronic stable angina","volume":"1","author":"Bala Subramanian","year":"1983","journal-title":"J Am Coll Cardiol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB75|cit75","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/pmj.79.935.522","article-title":"Effects of diltiazem on platelet activation and cytosolic calcium during percutaneous transluminal coronary angioplasty","volume":"79","author":"Dai","year":"2003","journal-title":"Postgrad Med J"},{"issue":"Suppl. A","key":"10.1111\/j.1368-5031.2005.00520.x-BIB76|cit76","doi-asserted-by":"crossref","first-page":"A36","DOI":"10.1093\/eurheartj\/18.suppl_A.36","article-title":"Calcium antagonist treatment, sympathetic activity and platelet function","volume":"18","author":"Hjemdahl","year":"1997","journal-title":"Eur Heart J"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB77|cit77","first-page":"165","article-title":"Short-term effects of withdrawing angiotensin converting enzyme inhibitor therapy on home self-measured blood pressure in hypertensive patients","volume":"11","author":"Vauer","year":"1998","journal-title":"J Hypertens"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB78|cit78","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1472-8206.1996.tb00603.x","article-title":"Interruption of prolonged ramipril treatment in hypertensive patients: effects on the rennin-angiotensin system","volume":"10","author":"Stephan","year":"1996","journal-title":"Fundam Clin Pharmacol"},{"key":"10.1111\/j.1368-5031.2005.00520.x-BIB79|cit79","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.ejheart.2003.10.009","article-title":"Endothelial dysfunction in congestive heart failure: ACE inhibition vs. angiotensin II antagonism","volume":"6","author":"Schafer","year":"2004","journal-title":"Eur J Heart Fail"}],"container-title":["International Journal of Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1368-5031.2005.00520.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1368-5031.2005.00520.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,1,28]],"date-time":"2022-01-28T06:05:34Z","timestamp":1643349934000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1368-5031.2005.00520.x"}},"subtitle":["Withdrawal Syndrome and Antihypertensive Drug Withdrawal"],"short-title":[],"issued":{"date-parts":[[2005,4,12]]},"references-count":79,"journal-issue":{"issue":"5"},"URL":"https:\/\/doi.org\/10.1111\/j.1368-5031.2005.00520.x","relation":{},"ISSN":["1368-5031"],"issn-type":[{"value":"1368-5031","type":"print"}],"subject":[],"published":{"date-parts":[[2005,4,12]]}}}